Danaher Lays Out 1Q, 2021 Guidance
January 28 2021 - 5:55AM
Dow Jones News
By Dave Sebastian
Danaher Corp. said it expects core revenue, including Cytiva, to
grow in the mid to high-teens range in the first quarter, as it
reported lower profit and higher sales for the fourth quarter.
The conglomerate said it expects core revenue, including Cytiva,
to grow by low-double digits for the full year.
Danaher acquired Cytiva, a life sciences company, in 2020.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
January 28, 2021 06:40 ET (11:40 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Danaher (NYSE:DHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Danaher (NYSE:DHR)
Historical Stock Chart
From Apr 2023 to Apr 2024
